Related references
Note: Only part of the references are listed.Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
Xiao-Jun Yang et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
Hiroyuki Narahara et al.
GASTRIC CANCER (2011)
Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer
Xiao-Dong Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Phase II study of a combination of irinotecan and S-1 in patients with advanced gastric cancer (OGSG0002)
Noriya Uedo et al.
ONCOLOGY (2007)
Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer
Ryohei Kawabata et al.
ONCOLOGY (2007)
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer
E. Mochiki et al.
BRITISH JOURNAL OF CANCER (2006)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma
JA Ajani et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
K Sumpter et al.
BRITISH JOURNAL OF CANCER (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer
K Fujitani et al.
ONCOLOGY (2005)
Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer
Y Yonemura et al.
CANCER LETTERS (2004)
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions
Y Yamada et al.
ANNALS OF ONCOLOGY (2001)
Share Paper
